for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

OFFICIAL CORRECTION-BRIEF-Lonza CFO Comments On Drug Substance Production For Moderna COVID-19 Vaccine - J.P.Morgan Conf

(Corrects production figure to include annual production, not first quarter 2021)

Jan 13 (Reuters) - Lonza Group AG:

* LONZA GROUP CFO CONFIRMS THAT LONZA FORECASTS THE PRODUCTION OF DRUG SUBSTANCE EQUIVALENT TO 400 MILLION DOSES OF THE MODERNA COVID-19 VACCINE PER YEAR ONCE FULLY OPERATIONAL, AND NOT OVER THE FIRST QUARTER OF 2021 Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up